文献速递肝病

酒精相关肝硬化肝移植等待者因临床改善可显著退组

A notable proportion of liver transplant candidates with alcohol-related cirrhosis can be delisted because of clinical improvement.
PubMed 文献 · J Hepatol · 2021-03-18

BACKGROUND & AIMS: To what extent patients with alcohol-related decompensated cirrhosis can improve until recovery from decompensation remains unclear.…

要点

  • 酒精相关失代偿期肝硬化等待肝移植者中8.6%因改善退组,中位时间29个月
  • 低MELD评分和高血小板独立预测退组,女性退组概率更高
  • 退组后5年无肝相关死亡或移植的累积概率为76%

核心结论

  • 相当比例的酒精相关肝硬化肝移植等待者可因临床改善而退组,低MELD评分和高血小板可预测退组。

主要发现

  • 低MELD评分、高血小板及女性或较矮身高独立与因改善退组相关,戒酒时间在多变量分析中未达统计学显著性(p=0.055)。
  • 退组后5年无肝相关死亡或肝移植的累积概率为76%,与因改善退组的HCV相关失代偿期肝硬化患者相似。

关键数值与推荐

  • 退组标准未预先设定;多变量分析中戒酒时间与退组的关联p=0.055。

临床怎么用

  • 早期识别有改善潜力的酒精相关肝硬化患者可能避免不必要的肝移植。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: To what extent patients with alcohol-related decompensated cirrhosis can improve until recovery from decompensation remains unclear. We aimed to investigate the probability of recovery and delisting due to improvement in patients with alcohol-related decompensated cirrhosis on the waiting list (WL) for liver transplantation (LT). METHODS: We conducted a registry-based, multicenter, retrospective study including all patients admitted to the LT WL in Catalonia (Spain) with the indication of alcohol-, HCV-, cholestasis- or non-alcoholic steatohepatitis-related decompensated cirrhosis between January 2007 and December 2018. Competing-risk analysis was used to investigate variables associated with delisting due to improvement in patients with alcohol-related decompensated cirrhosis. Criteria for delisting after improvement were not predefined. Outcomes of patients after delisting were also studied. RESULTS: One-thousand and one patients were included, 420 (37%) with alcohol-related decompensated cirrhosis. Thirty-six (8.6%) patients with alcohol-related decompensated cirrhosis were delisted after improvement at a median time of 29 months after WL admission. Lower model for end-stage liver disease (MELD) score, higher platelets and either female sex or lower height were independently associated with delisting due to improvement, while time of abstinence did not reach statistical significance in multivariate analysis (p = 0.055). Five years after delisting, the cumulative probability of remaining free from liver-related death or LT was 76%, similar to patients with HCV-related decompensated cirrhosis delisted after improvement. CONCLUSIONS: A significant proportion of LT candidates with alcohol-related cirrhosis can be delisted due to improvement, which is predicted by low MELD score and higher platelet count at WL admission. Women also have a higher probability of being delisted after improvement, partially due to reduced early access to LT for height discrepancies. Early identification of patients with potential for improvement may avoid unnecessary transplants. LAY SUMMARY: Patients with alcohol-related cirrhosis can improve until being delisted in approximately 9% of cases. Low model for end-stage liver disease score and high platelet levels at admission predict delisting after improvement, and women have higher probabilities of being delisted due to improvement. Long-term outcomes after delisting are generally favorable.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Pose E, Torrents A, Reverter E, et al. A notable proportion of liver transplant candidates with alcohol-related cirrhosis can be delisted because of clinical improvement. J Hepatol. 2021. PMID: 33746085. doi:10.1016/j.jhep.2021.02.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。